Healthcare & Biotech
Exin Therapeutics
AI drug discovery platform for neurotherapeutics
We use AI and high-throughput mouse studies to discover therapeutics that modify neural activity in the brain. The initial focus is on epilepsies associated with autism and Parkinson’s disease with the potential to expand to any neurological disorder underlined by a dysfunction in neural activity. Our R&D is guided by AI models trained on…
- Therapeutics
- Neurotechnology
- Biotech
- Website
- exintherapeutics.com
- Headquarters
- San Francisco, CA, USA
- Team size
- 2-10 people
- Founded
- 2025
- Demo
- 20 min demo
Similar companies
CircumventUtilizing monogenic disorders to inform and solve highly complex…
Eris BiotechOur drugs engage the immune system to fight tumors
AlixiaTargeting the Tumor Ecosystem to address cancer drug resistance.
Equator TherapeuticsWe are developing a drug to burn calories and increase metabolism…
Origami Therapeutics, Inc.Oral drugs to halt neurodegeneration
Velorum TherapeuticsBreakthrough medicines unlocking the biology of heme
Sensible BiotechnologiesUnlocking the next generation of mRNA medicines
Serinus BiosciencesCombinations therapy by rational design